CTOR
Citius Oncology, Inc.
NASDAQ · Healthcare · Drug Manufacturers - General · US
$0.86
+8.56%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 8.10x
- P/E 2028E
- 1.76x
- P/S forward
- 1.15x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.98x
- Price / sales
- 11.25x
- Price / cash flow
- -4.06x
Enterprise value
- Enterprise value
- $73.6M
- EV / sales
- 10.36x
- EV / EBITDA
- -1.71x
- EV / EBIT
- -1.56x
- Market cap
- $80.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026